Country: কানাডা
ভাষা: ইংরেজি
সূত্র: Health Canada
SALBUTAMOL (SALBUTAMOL SULFATE)
DOMINION PHARMACAL
R03AC02
SALBUTAMOL
1MG
SOLUTION
SALBUTAMOL (SALBUTAMOL SULFATE) 1MG
INHALATION
2.5ML
Prescription
SELECTIVE BETA 2-ADRENERGIC AGONISTS
Active ingredient group (AIG) number: 0108887007; AHFS:
MARKETED
1997-05-16
PRODUCT MONOGRAPH PR DOM-SALBUTAMOL RESPIRATOR SOLUTION Salbutamol Sulphate Inhalation Solution 0.05%; 0.1%; 0.2%; 0.5% 0.5 mg/mL; 1 mg/mL; 2 mg/mL; 5 mg/mL BRONCHODILATOR Beta 2 -adrenergic stimulant DOMINION PHARMACAL 6111 Royalmount Ave., Suite 100 Montréal, Canada H4P 2T4 Date of Revision: 02 November, 2016 Submission Control No: 198847 _ _ _Dom-SALBUTAMOL RESPIRATOR SOLUTION Product Monograph Page 2 of 36_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ...................................................... 3 SUMMARY PRODUCT INFORMATION ..................................................................... 3 INDICATIONS AND CLINICAL USE .......................................................................... 3 CONTRAINDICATIONS ............................................................................................... 3 WARNINGS AND PRECAUTIONS .............................................................................. 4 ADVERSE REACTIONS ............................................................................................... 7 DRUG INTERACTIONS ................................................................................................ 8 DOSAGE AND ADMINISTRATION ............................................................................ 9 OVERDOSAGE ........................................................................................................... 12 ACTION AND CLINICAL PHARMACOLOGY ......................................................... 12 STORAGE AND STABILITY ...................................................................................... 14 DOSAGE FORMS, COMPOSITION AND PACKAGING ........................................... 14 PART II: SCIENTIFIC INFORMATION ........................................................................... 15 PHARMACEUTICAL INFORMATION ...................................................................... 15 CLINICAL TRIALS ..................................................................................................... 16 DET সম্পূর্ণ নথি পড়ুন